Search results
...Announces Positive Preclinical Study Results For Its Novel Oral ketamine Analog, Ketamir-2,...
KOLR - KSFX Ozarks· 4 days agoThe highly encouraging study results further MIRA's goal of submitting an Investigational New Drug Application (IND) to the U.S...
MIRA reports promising Ketamir-2 study, eyes FDA submission By Investing.com
Investing.com· 3 days agoThe preclinical research, conducted by Pharmaseed Ltd., compared the effects of Ketamir-2 to oral ...
Easing federal marijuana rules: There’s still a long way to go
South Carolina Daily Gazette via Yahoo News· 5 days agoNearly three weeks after the U.S. Drug Enforcement Administration proposed loosening a federal...
Trouble for ecstasy? What MDMA’s FDA setback could mean for psychedelics
NPR· 15 hours agoNath says his company, Compass, has no plans to change its psilocybin trial design or protocol, but this does reinforce the need to show “consistency” with the therapy component and collect ...
Some psychedelic medicine developers want to ditch the therapy aspect. What could go wrong?
Salon via Yahoo News· 6 days agoPsychedelics, on the other hand, are considered to be so life-altering, emotional and sometimes...
What is MDMA? | National Institute on Drug Abuse
Mountain View Telegraph· 23 hours agoMDMA is a synthetic drug that acts as a stimulant and hallucinogen.15–17 It produces an energizing effect, distortions in time and perception, and enhanced enjoyment from ...
FDA panel rejects MDMA-assisted therapies for PTSD despite high hopes from veterans
Fox News· 18 hours agoA U.S. Food and Drug Administration (FDA) panel rejected MDMA-based treatments for post-traumatic...